Belite Bio Inc (BLTE)
NASDAQ: BLTE
· Real-Time Price · USD
63.42
1.61 (2.60%)
At close: Aug 20, 2025, 3:59 PM
62.20
-1.92%
After-hours: Aug 20, 2025, 04:18 PM EDT
Belite Bio Inc Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -42.55K | -36.14K | -33.03K | -35.29K | -32.61K | -31.63K | -31.43K | -22.89K | -18.47K | -12.65K | -8.34K | -8.41K | -8.38K | -9.67K | -9.01K | -8.36K | -7.06K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | -22.5K | -22.5K | -22.5K | -22.5K | 7.50 | 7.51K | 7.51K | 7.52K | 7.52K | 24.00 | 20.50 |
Stock-Based Compensation | 8.99K | 8.99K | 3.82K | 3.82K | 3.82K | 3.82K | 1.48K | 2.22K | 2.22K | 2.22K | 297.50 | 321.00 | 925.50 | 1.53K | 2.23K | 1.71K | 1.54K |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 301.00 | 301.00 | 297.50 | 294.00 | 28.00 | 63.00 | 4.50 |
Other Non-Cash Items | 33.56K | 27.16K | 29.21K | 31.47K | 28.79K | 27.81K | 29.94K | 21.41K | 16.99K | 11.16K | 6.48K | 5.78K | 3.4K | 2.34K | 1.73K | 29.00 | 5.00 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -5.35M | -5.35M | -5.35M | -5.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | -480K | -480K | -480K | -480K | 301.00 | 160.3K | 160.3K | 160.29K | 160.03K | 64.00 | 7.00 |
Operating Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -5.85M | -5.85M | -5.85M | -5.85M | -1.25K | -1.87M | -1.87M | -1.87M | -1.87M | -6.53K | -5.49K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | 55.5K | 55.5K | 55.5K | 55.5K | -18.5K | -37K | -37.04K | -37.07K | -18.58K | -94 | -5.06K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -431K | -431K | -431K | -431K | 1.50 | 18.5K | 18.51K | 18.52K | 23.52K | 10.02K | 15.01K |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -375.5K | -375.5K | -375.5K | -375.5K | 1.50 | -18.5K | -18.53K | -18.56K | -18.57K | -79 | -5.05K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 37.17M | 37.17M | 37.17M | 37.17M | -291.5 | -204.04K | -407.79K | -611.54K | -600.33K | -385.66K | -178.8K |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 37.17M | 37.17M | 37.17M | 37.17M | -291.5 | -204.04K | -407.79K | -611.54K | -600.33K | -385.66K | -178.8K |
Net Cash Flow | n/a | n/a | n/a | -2.9M | 16.7M | 16.7M | 54.45M | 57.35M | 37.75M | 37.75M | -2.07M | -4.14M | -6.21M | -8.27M | -305.25K | 8.16M | 9.73M |
Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -5.8M | -5.8M | -5.8M | -5.8M | -19.75K | -1.91M | -1.91M | -1.91M | -1.89M | -6.63K | -10.54K |